期刊文献+

与调血脂药物相关的相互作用 被引量:4

Lipid regulating agents related drug interactions
原文传递
导出
摘要 通过检索Medline数据库,就目前有关调血脂药物的相互作用研究进行分类和综述,对有明显临床意义的不良药物相互作用进行重点介绍,以引起临床医师药师重视,供其在临床药物治疗中参考。 By searching the Medline Database, we reviewed and classified the lipid regulating agents related drug interactions. The key clinical significant drug interactions were then introduced to be referred by the health caregivers.
作者 金阳 刘治军
出处 《临床药物治疗杂志》 2013年第4期1-8,37,共9页 Clinical Medication Journal
关键词 调血脂类药物 他汀性肌病 阿托伐他汀 药物相互作用 Lipid regulating agents Statin-induced myopathy Atorvastatin Drug interactions
  • 相关文献

参考文献58

  • 1Bliznakov EG.Lipid-lowering drugs (statins), cholesterol, and coenzyme QI0. The Baycol case--a modern Pandora's box[J]. Biomed Pharmacother, 2002, 56(1): 56-59.
  • 2Brucker! E, Hayem G, Dejager S, et al. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study[J]. Cardiovasc Drugs Ther, 2005, 19(6): 403-414.
  • 3Ucar M, Mjorndal T, Dahlqvist R.HMG-CoA reductase inhibitors and myotoxicity[J]. Drug Saf, 2000, 22(6): 441-457.
  • 4CREOLE Study Team.Brucker! E, Simonetta C, et al.Compliance with fluvastatin treatment characterization of the noncompliant population within a population of 3845 patients with hyperlipidemia[J]. J Clin Epidemiol, 1999,52(6): 589-594.
  • 5Jacobson TA. Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia[J]. Mayo Clin Proc, 2008, 83(6): 687-700.
  • 6Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy[J]. JAMA, 2003, 289(13): 1681-1690.
  • 7Davidson MH.Controversy surrounding the safety of cerivastatin[J]. Expert Opin Drug Saf, 2002, 1(3): 207-212.
  • 8Neuvonen PJ, Niemi M, Backman JT. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance[J]. Clin Pharmacol Ther, 2006, 80(6): 565-581.
  • 9Neuvonen PJ, Backman JT, Niemi M. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin[J]. Clin Pharmacokinet, 2008, 47(7): 463-474.
  • 10Fujino H, Saito T, Tsunenari Y, et al. Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors[J]. Xenobiotica, 2004, 34(11-12): 961-971.

同被引文献54

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部